ALT Behavior During Follow-up in Patients With Different Serologic Profiles at the End of the Observation Period
| Serologic Profile at End of Follow-up . | ALT Profile During Follow-up: No. of Patients (%) . | |||||
|---|---|---|---|---|---|---|
| Group . | Anti-HCV . | HCV-RNA . | No. of Patients . | Constantly Normal . | Constantly Elevated . | Fluctuating . |
| A | − | − | 47 | 42 (89) | 0 | 5 (11) |
| B | − | + | 20 | 17 (85) | 0 | 3 (15) |
| C | + | + | 28 | 6 (22) | 4 (14) | 18 (64) |
| D | + | − | 19 | 16 (84) | 0 | 3 (16) |
| Serologic Profile at End of Follow-up . | ALT Profile During Follow-up: No. of Patients (%) . | |||||
|---|---|---|---|---|---|---|
| Group . | Anti-HCV . | HCV-RNA . | No. of Patients . | Constantly Normal . | Constantly Elevated . | Fluctuating . |
| A | − | − | 47 | 42 (89) | 0 | 5 (11) |
| B | − | + | 20 | 17 (85) | 0 | 3 (15) |
| C | + | + | 28 | 6 (22) | 4 (14) | 18 (64) |
| D | + | − | 19 | 16 (84) | 0 | 3 (16) |